Piperazinylcarbonylquinolines and -isoquinolines
Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; hun |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VAN AMSTERDAM BOETTCHER HENNING HARTING JUERGEN SEYFRIED CHRISTOPH BARTOSZYK GERD |
| description | Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Hutington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HU230250B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HU230250B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HU230250B13</originalsourceid><addsrcrecordid>eNrjZDAIyCxILUqsysyrzElOLErKB9KFpZl5-TmZeanFCol5KQq6mcX5CCEeBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLvEWpkbGBkauBkaExYBQBEayux</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Piperazinylcarbonylquinolines and -isoquinolines</title><source>esp@cenet</source><creator>VAN AMSTERDAM ; BOETTCHER HENNING ; HARTING JUERGEN ; SEYFRIED CHRISTOPH ; BARTOSZYK GERD</creator><creatorcontrib>VAN AMSTERDAM ; BOETTCHER HENNING ; HARTING JUERGEN ; SEYFRIED CHRISTOPH ; BARTOSZYK GERD</creatorcontrib><description>Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Hutington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).</description><language>eng ; hun</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151130&DB=EPODOC&CC=HU&NR=230250B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151130&DB=EPODOC&CC=HU&NR=230250B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VAN AMSTERDAM</creatorcontrib><creatorcontrib>BOETTCHER HENNING</creatorcontrib><creatorcontrib>HARTING JUERGEN</creatorcontrib><creatorcontrib>SEYFRIED CHRISTOPH</creatorcontrib><creatorcontrib>BARTOSZYK GERD</creatorcontrib><title>Piperazinylcarbonylquinolines and -isoquinolines</title><description>Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Hutington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAIyCxILUqsysyrzElOLErKB9KFpZl5-TmZeanFCol5KQq6mcX5CCEeBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLvEWpkbGBkauBkaExYBQBEayux</recordid><startdate>20151130</startdate><enddate>20151130</enddate><creator>VAN AMSTERDAM</creator><creator>BOETTCHER HENNING</creator><creator>HARTING JUERGEN</creator><creator>SEYFRIED CHRISTOPH</creator><creator>BARTOSZYK GERD</creator><scope>EVB</scope></search><sort><creationdate>20151130</creationdate><title>Piperazinylcarbonylquinolines and -isoquinolines</title><author>VAN AMSTERDAM ; BOETTCHER HENNING ; HARTING JUERGEN ; SEYFRIED CHRISTOPH ; BARTOSZYK GERD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HU230250B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VAN AMSTERDAM</creatorcontrib><creatorcontrib>BOETTCHER HENNING</creatorcontrib><creatorcontrib>HARTING JUERGEN</creatorcontrib><creatorcontrib>SEYFRIED CHRISTOPH</creatorcontrib><creatorcontrib>BARTOSZYK GERD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VAN AMSTERDAM</au><au>BOETTCHER HENNING</au><au>HARTING JUERGEN</au><au>SEYFRIED CHRISTOPH</au><au>BARTOSZYK GERD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Piperazinylcarbonylquinolines and -isoquinolines</title><date>2015-11-30</date><risdate>2015</risdate><abstract>Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Hutington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; hun |
| recordid | cdi_epo_espacenet_HU230250B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Piperazinylcarbonylquinolines and -isoquinolines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T07%3A44%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VAN%20AMSTERDAM&rft.date=2015-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHU230250B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |